Clinical Trial Update: Low Dose Multi-OIT for Food Allergy (LoMo) [Phase 2]

View source ↗

Summary

Phase 2 trial update for Low Dose Multi-OIT for Food Allergy (LoMo) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Food Allergy

Drugs mentioned

• Oral Immunotherapy (OIT) (oral immunotherapy)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Food Allergy | Phase 2 | Status: COMPLETED